These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 6541714

  • 1. A prospective randomized trial of central venous catheter removal versus intravenous amphotericin B in febrile neutropenic patients.
    Lazarus HM, Lowder JN, Anderson JM, Herzig RH.
    JPEN J Parenter Enteral Nutr; 1984; 8(5):501-5. PubMed ID: 6541714
    [Abstract] [Full Text] [Related]

  • 2. Fungal infection and fever of unknown origin in neutropenic patients.
    Bodey GP.
    Am J Med; 1986 May 30; 80(5C):112-9. PubMed ID: 3717185
    [No Abstract] [Full Text] [Related]

  • 3. Three-step empiric treatment for severely neutropenic patients with fever: ceftazidime--vancomycin--amphotericin B.
    Koeppler H, Pflueger KH, Seitz R, Havemann K.
    Infection; 1989 May 30; 17(3):142-5. PubMed ID: 2661438
    [Abstract] [Full Text] [Related]

  • 4. Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group.
    Am J Med; 1989 Jun 30; 86(6 Pt 1):668-72. PubMed ID: 2658574
    [Abstract] [Full Text] [Related]

  • 5. Empiric amphotericin B therapy: the need for a reappraisal.
    Fraser IS, Denning DW.
    Blood Rev; 1993 Dec 30; 7(4):208-14. PubMed ID: 8130683
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Low-dose amphotericin B lipid complex vs. conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial.
    Subirà M, Martino R, Gómez L, Martí JM, Estany C, Sierra J.
    Eur J Haematol; 2004 May 30; 72(5):342-7. PubMed ID: 15059069
    [Abstract] [Full Text] [Related]

  • 8. Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
    Tan BH, Low JG, Chlebicka NL, Kurup A, Cheah FK, Lin RT, Goh YT, Wong GC.
    Int J Infect Dis; 2011 May 30; 15(5):e350-6. PubMed ID: 21397541
    [Abstract] [Full Text] [Related]

  • 9. Rapid infusion amphotericin B: effective and well-tolerated therapy for neutropenic fever.
    Spitzer TR, Creger RJ, Fox RM, Lazarus HM.
    Pharmatherapeutica; 1989 May 30; 5(5):305-11. PubMed ID: 2748690
    [Abstract] [Full Text] [Related]

  • 10. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes.
    Jeddi R, Achour M, Amor RB, Aissaoui L, Bouterâa W, Kacem K, Lakhal RB, Abid HB, BelHadjAli Z, Turki A, Meddeb B.
    Hematology; 2010 Feb 30; 15(1):28-32. PubMed ID: 20132659
    [Abstract] [Full Text] [Related]

  • 11. Design of clinical trials of empiric antifungal therapy in patients with persistent febrile neutropenia: considerations and critiques.
    Sobel JD.
    Pharmacotherapy; 2006 Jun 30; 26(6 Pt 2):47S-54S. PubMed ID: 16716122
    [Abstract] [Full Text] [Related]

  • 12. A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial II.
    Schiel X, Link H, Maschmeyer G, Glass B, Cornely OA, Buchheidt D, Wilhelm M, Silling G, Helmerking M, Hiddemann W, Ostermann H, Hentrich M.
    Infection; 2006 Jun 30; 34(3):118-26. PubMed ID: 16804654
    [Abstract] [Full Text] [Related]

  • 13. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
    Cordonnier C, Pautas C, Maury S, Vekhoff A, Farhat H, Suarez F, Dhédin N, Isnard F, Ades L, Kuhnowski F, Foulet F, Kuentz M, Maison P, Bretagne S, Schwarzinger M.
    Clin Infect Dis; 2009 Apr 15; 48(8):1042-51. PubMed ID: 19281327
    [Abstract] [Full Text] [Related]

  • 14. Prophylaxis of Candida albicans infection in neutropenic mice with liposome-encapsulated amphotericin B.
    Lopez-Berestein G, Hopfer RL, Mehta R, Mehta K, Hersh EM, Juliano RL.
    Antimicrob Agents Chemother; 1984 Mar 15; 25(3):366-7. PubMed ID: 6721469
    [Abstract] [Full Text] [Related]

  • 15. Empiric therapy with amphotericin B in febrile granulocytopenic patients.
    Walsh TJ, Lee J, Lecciones J, Rubin M, Butler K, Francis P, Weinberger M, Roilides E, Marshall D, Gress J.
    Rev Infect Dis; 1991 Mar 15; 13(3):496-503. PubMed ID: 1866556
    [Abstract] [Full Text] [Related]

  • 16. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
    Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffalli J, Yanovich S, Stiff P, Greenberg R, Donowitz G, Schuster M, Reboli A, Wingard J, Arndt C, Reinhardt J, Hadley S, Finberg R, Laverdière M, Perfect J, Garber G, Fioritoni G, Anaissie E, Lee J, National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    N Engl J Med; 2002 Jan 24; 346(4):225-34. PubMed ID: 11807146
    [Abstract] [Full Text] [Related]

  • 17. Pharmacoeconomic analysis of liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.
    Cagnoni PJ, Walsh TJ, Prendergast MM, Bodensteiner D, Hiemenz S, Greenberg RN, Arndt CA, Schuster M, Seibel N, Yeldandi V, Tong KB.
    J Clin Oncol; 2000 Jun 24; 18(12):2476-83. PubMed ID: 10856108
    [Abstract] [Full Text] [Related]

  • 18. Economic evaluation of caspofungin versus liposomal amphotericin B for empiric antifungal treatment in patients with neutropenic fever in Italy.
    Stam WB, Aversa F, Kumar RN, Jansen JP.
    Value Health; 2008 Jun 24; 11(5):830-41. PubMed ID: 18494752
    [Abstract] [Full Text] [Related]

  • 19. [Case report: a Fusarium fungaemia].
    Yücesoy M, Ergon MC, Oren H, Gülay Z.
    Mikrobiyol Bul; 2004 Jul 24; 38(3):265-71. PubMed ID: 15490848
    [Abstract] [Full Text] [Related]

  • 20. Empiric treatment with once-daily cefonicid and gentamicin for febrile non-neutropenic pediatric cancer patients with indwelling central venous catheters.
    Averbuch D, Makhoul R, Rotshild V, Weintraub M, Engelhard D.
    J Pediatr Hematol Oncol; 2008 Jul 24; 30(7):527-32. PubMed ID: 18797200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.